Document is current

Article History

Received: 5 May 2026

Accepted: 7 August 2026

First Online: 28 August 2026

Declarations

Conflict of Interest: A.B. Dua has received consulting fees from AbbVie, Amgen, AZ, GSK, Novartis, and Sanofi; has participated in clinical trials or received grant support from Amgen, Novartis, and Rheumatology Research Foundation; and was on the Board of Directors for Vasculitis Foundation and Rheumatology Research Foundation. A. Kadakia, P. Zueger, N. Zerad, and A. Setty are employees of AbbVie and may own stock or stock options. S. Marwaha is a former employee of Adelphi Real World and current employee of Research Partnership. W. Jones is an employee of Adelphi Real World. V. Devauchelle-Pensec has received grants from Fresenius and consultancy fees from AbbVie and Novartis.

Ethical Approval: Patients provided informed consent for use of their anonymized and aggregated data for research and scientific publication. All data were collected, aggregated, and de-identified prior to receipt. Data collection was performed in line with national market research and privacy regulations according to the European Pharmaceutical Marketing Research Association guidelines, and ethical exemption was sought from the Pearl Institutional Review Board. The study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments.

Medical Writing, Editorial, and Other Assistance: Medical writing services were provided by Samantha D. Francis Stuart, PhD, of Avalere Health, Ltd., and funded by AbbVie.